The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Nuvation Bio Inc shares valued at $17,100 were purchased by Markel Stacy on Jun 18 ’25. At $1.71 per share, Markel Stacy acquired 10,000 shares. The insider’s holdings grew to 29,591 shares worth approximately $0.11 million following the completion of this transaction.
Also, Sauvage Philippe purchased 4,000 shares, netting a total of over 7,160 in proceeds. Following the buying of shares at $1.79 each, the insider now holds 9,902 shares.
Before that, Sauvage Philippe had added 3,300 shares to its account. In a trade valued at $6,056, the Chief Financial Officer bought Nuvation Bio Inc shares for $1.83 each. Upon closing the transaction, the insider’s holdings increased to 3,300 shares, worth approximately $21837.4.
As published in their initiating research note from Jefferies on September 30, 2025, Nuvation Bio Inc [NUVB] has been a Buy and the price target has been revised to $10. Analysts at Citizens JMP started covering the stock with ‘”a Mkt outperform”‘ outlook in a report released in late April. As of March 27, 2024, Jefferies has increased its “Hold” rating to a “Buy” for NUVB. Earlier on March 26, 2024, BTIG Research upgraded its rating. Their new recommendation was “a Buy” for NUVB stock which previously was a “a Neutral”.
Analyzing NUVB Stock Performance
The stock’s lowest price that day was $3.53, but it reached a high of $3.83 in the same session. During the last five days, there has been a surge of approximately 14.20%. Over the course of the year, Nuvation Bio Inc shares have jumped approximately 54.81%. Shares of the company reached a 52-week high of $4.09 on 09/05/25 and a 52-week low of $1.54 on 04/07/25.
Support And Resistance Levels for Nuvation Bio Inc (NUVB)
According to the 24-hour chart, there is a support level at 3.54, which, if violated, would cause prices to drop to 3.39. In the upper region, resistance lies at 3.84. The next price resistance is at 3.99. RSI (Relative Strength Index) is 66.21 on the 14-day chart, showing neutral technical sentiment.
Is Nuvation Bio Inc subject to short interest?
Stocks of Nuvation Bio Inc saw a sharp steep in short interest on 2025-09-15 dropping by -1.05 million shares to 68.02 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 69.07 million shares. A decline of -1.55% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 10.32 of the overall float, the days-to-cover ratio (short ratio) decline to 10.32.
Which companies own the most shares of Nuvation Bio Inc (NUVB)?
In terms of Nuvation Bio Inc share price expectations, FactSet research, analysts set an average price target of 6 in the next 12 months, up nearly 62.16% from the previous closing price of $3.7. Analysts anticipate Nuvation Bio Inc stock to reach 6 by 2025, with the lowest price target being 6. In spite of this, 4 analysts ranked Nuvation Bio Inc stock as Buy at the end of 2025. On January 06, 2023, Jefferies assigned a price target of “a Hold” to the stock and downgraded coverage with a $2.
